ICLS

Integra LifeSciences is a commercial-stage medical technology company focused on surgical, neurologic, and regenerative care. The company markets a broad portfolio spanning neurosurgery, neurocritical care, ENT, surgical instrumentation, and wound reconstruction products. Its offerings include tissue ablation systems, dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, balloon dilation technologies, and regenerative tissue matrices used in wound and soft-tissue repair. Integra serves hospitals, surgery centers, and other healthcare providers globally through direct sales and distribution channels. The business is not a drug-development biotech company; it is primarily a medical device and regenerative tissue products company with established commercial revenue.